Navigation Links
Patient Navigators Help Minority, Low-Income Cancer Patients Get Life-Saving Treatments

LOS ANGELES, Oct. 30 /PRNewswire/ -- Volunteers who guide low-income and minority cancer patients through cancer treatment, called lay patient navigators (LPN), help them to overcome major obstacles that prevent them from receiving quality care and achieving better outcomes, according to a study presented October 28, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.

Minority and low-income cancer patients continue to receive inferior care in the detection and treatment of cancer, compared to the general population. They are also under-represented in cancer clinical trials, which can potentially save or extend the lives of trial participants, especially those who have few treatment options.

To better understand how LPNs can help these at-risk patients, researchers studied nearly 500 African American and Latino cancer patients with mean family incomes below the poverty level. Almost two-thirds (60 percent) of patients studied accepted help from LPNs to overcome their barriers to getting cancer treatment. Results show that the time it took to reduce these barriers decreased from an average of 42 days to only one day. The study also showed that LPNs offered patients more access to participation in cancer clinical trials.

The study was conducted by the Urban Latino African American Cancer Disparities Project to identify and confront the root causes of treatment disparities in underserved communities and offer better access to clinical trials. It was supported by a grant from the National Cancer Institute's Cancer Disparity Research Program.

"Our study shows that LPNs can play an important role in reducing the healthcare disparities among minority and low-income patients by being their patient advocates," said David Khan, M.D., lead author of the study and a radiation oncologist at Centinela Freeman Medical Center in Inglewood, Calif. "These patient navigator programs should become an essential part of our healthcare delivery system to provide these patients with better access to quality care."

Many patients in the study faced multiple barriers in getting care, which impacted the start and completion of getting cancer treatment. Lack of transportation to healthcare providers was cited as the greatest obstacle in getting quality care, while inadequate finances to pay for medical care was also a significant challenge among these patients.

For more information on radiation therapy, visit

The abstract, "Evolution of a Novel Radiation Oncology Cancer Disparities Research Program in an Indigent Los Angeles Community," will be presented for poster viewing at 10:00 a.m., Sunday, October 28, 2007. To speak to the lead study author, David Khan, M.D., please call Beth Bukata or Nicole Napoli October 28-31, 2007, in the ASTRO Press Room at the Los Angeles Convention Center at 213-743-6222 or 213-743-6223. You may also e-mail them at or

SOURCE American Society for Therapeutic Radiology and Oncology
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Monitoring Patient Glucose Levels: New Advances in software make it easier
2. Managing Preanalytical Processes for Patient Safety
3. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
4. Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
5. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
6. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
7. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
8. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
9. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
Post Your Comments:
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... 52" report to their offering. ... creates a favourable commercial environment for MedImmune to enter. The ... that will serve to drive considerable growth for effective anti-influenza ... to cap sales considerably, but development is still in its ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Conventional wisdom ... of success. In terms of the latter, setting the bar too high can result ... more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... June 19, ... the dangers associated with chronic pain and the benefits of holistic treatments, Serenity ... who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Global law firm ... 2016 Legal Elite. The attorneys chosen by their peers for this recognition are considered ... Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal Elite ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and the network’s ... the world, and the most handsome men, look naturally attractive. Plastic surgery should ...
Breaking Medicine News(10 mins):